Bernard Garcia
Internal Medicine · Fort Lauderdale, FLNPI 1447218870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,069 and has fallen 94.7% since, to $110 in 2024. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$737
- Johnson & Johnson$678
- AbbVie$637
- Novo Nordisk$548
- Harmony Biosciences LLC$443
- Gilead$422
- plus $3K from 30 others
Across 391 payments — averaging $15,094 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$2.9M
- AbbVie$1.9M
- Partner Therapeutics, Inc.$551K
- AstraZeneca$139K
- Romark Laboratories, LC$63K
- Pfizer$61K
- plus $318K from 12 others
What the payments were for
- Consulting fees$130%
- Food & beverage$6,567100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 56 | $737 |
| Johnson & Johnson | 33 | $678 |
| AbbVie(2 entities) | 47 | $637 |
| Novo Nordisk | 33 | $548 |
| Harmony Biosciences LLC | 14 | $443 |
| Gilead | 18 | $422 |
| AstraZeneca | 22 | $386 |
| Amarin Pharma, Inc. | 19 | $324 |
| Pfizer | 15 | $258 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $257 |
| GSK | 7 | $240 |
| Novartis | 9 | $240 |
| Kvk-tech, Inc. | 27 | $194 |
| Boehringer Ingelheim | 9 | $179 |
| Lilly USA, LLC | 13 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $130 |
| Spineology Inc. | 1 | $89 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Viiv Healthcare Company | 4 | $67 |
| Astellas Pharma US Inc | 4 | $67 |
| Merck | 5 | $66 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Almatica Pharma LLC | 2 | $38 |
| Redhill Biopharma Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $31 |
| Philips North America LLC | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Shire North American Group Inc | 2 | $26 |
| Dexcom, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Quidel Corporation | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$125
- TRELEGY ELLIPTA$124
- Descovy$123
- ENTRESTO$116
- Repatha$111
How this compares
$6,586 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 63 | $374 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $224 |
| Lorazepam | 15 | $217 |
| Azithromycin | 24 | $64 |
| Prednisone | 24 | $42 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Lauderdale
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Sheetal SharmaFort Lauderdale$184K
- Evan WuFort Lauderdale$114K
- Haytham ElgammalMiami$2.2M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.